| |
| |
|
| Insider
Information: |
Whitnell Jeffrey A |
| Relationship: |
Director |
| City: |
Buffalo Grove |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
3,249,795 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$415,391 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,249,795 |
|
|
| Total
Value |
$415,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akorn Inc |
AKRX |
Interim CEO/CFO |
2009-04-20 |
62,775 |
2005-05-27 |
0 |
Premium* |
|
|
Elite Pharmaceuticals Inc |
ELTP |
Director |
2023-11-22 |
3,187,020 |
2011-02-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2023-11-22 |
4 |
A |
$0.04 |
$19,989 |
D/D |
547,657 |
3,187,020 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2022-08-28 |
4 |
A |
$0.04 |
$19,990 |
D/D |
459,536 |
2,639,363 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.07 |
$20,010 |
D/D |
295,570 |
2,179,827 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2020-08-20 |
4 |
A |
$0.09 |
$45,012 |
D/D |
516,781 |
1,884,257 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2018-02-26 |
4 |
A |
$0.12 |
$19,994 |
D/D |
161,374 |
1,367,476 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2017-02-23 |
4 |
A |
$0.23 |
$19,997 |
D/D |
88,679 |
1,206,102 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2016-02-16 |
4 |
A |
$0.25 |
$20,004 |
D/D |
81,549 |
1,117,423 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2015-03-05 |
4 |
A |
$0.34 |
$19,998 |
D/D |
58,475 |
1,035,874 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2014-02-25 |
4 |
A |
$0.09 |
$20,008 |
D/D |
220,106 |
977,399 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2013-03-07 |
4 |
A |
$0.08 |
$14,776 |
D/D |
184,706 |
757,293 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2012-03-20 |
4 |
A |
$0.10 |
$22,445 |
D/D |
231,633 |
572,587 |
0 |
- |
|
| ELTP |
Elite Pharmaceuticals Inc |
Director |
– • – |
2011-02-03 |
4 |
B |
$0.04 |
$13,638 |
D/D |
340,954 |
340,954 |
2.39 |
- |
|
| AKRX |
Akorn Inc |
Interim CEO/CFO |
• • – |
2009-04-20 |
4 |
D |
$0.93 |
$9,300 |
D/D |
(10,000) |
62,775 |
0 |
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2008-04-20 |
4 |
D |
$5.03 |
$50,300 |
D/D |
(10,000) |
72,775 |
0 |
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2007-11-13 |
4 |
S |
$6.89 |
$79,752 |
D/D |
(11,550) |
82,775 |
0 |
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2007-11-12 |
4 |
S |
$7.00 |
$27,006 |
D/D |
(3,858) |
94,325 |
0 |
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2007-04-20 |
4 |
D |
$7.38 |
$127,121 |
D/D |
(17,225) |
98,183 |
0 |
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2006-04-20 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
115,408 |
|
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2006-03-31 |
4 |
D |
$4.86 |
$31,255 |
D/D |
(6,431) |
15,408 |
|
- |
|
| AKRX |
Akorn Inc |
Chief Financial Officer |
• – – |
2005-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
21,839 |
21,839 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
